WS Canlife UK Equity Fund G AccumulationRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -9.3 | 21.1 | -0.7 | 9.6 | 5.3 | |
+/-Cat | -0.2 | 3.2 | 1.4 | 1.4 | -0.2 | |
+/-B’mrk | - | - | - | 2.0 | -0.8 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 02/05/2024 | GBX 164.31 | |
Day Change | 0.31% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B7FVJ541 | |
Fund Size (Mil) 28/03/2024 | GBP 536.49 | |
Share Class Size (Mil) 02/05/2024 | GBP 497.46 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.42% |
Investment Objective: WS Canlife UK Equity Fund G Accumulation |
To achieve capital growth, over any five year period, after all costs and charges have been taken. To invest directly and/or indirectly at least 80% of the assets by value in the shares of companies which are incorporated or domiciled in the United Kingdom. As part of the equities exposure the Sub-fund may also invest in Real Estate Investment Trusts (REITs). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Nigel Kennett 21/10/2013 | ||
Rino Shala 01/01/2019 | ||
Inception Date 18/10/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Bloomberg UK L&M&S Cap TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for WS Canlife UK Equity Fund G Accumulation | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 9.55 |
Shell PLC | Energy | 8.01 |
Unilever PLC | Consumer Defensive | 5.91 |
GSK PLC | Healthcare | 4.02 |
BP PLC | Energy | 3.80 |
Increase Decrease New since last portfolio | ||
WS Canlife UK Equity Fund G Accumulation |